RESEARCH NEWS 2013-12-27 Research News When researchers in the Diflunisal Trial Consortium gathered for a meeting last March, they had no idea what was in store. John Berk of Boston University reviewed their attempt to treat the rare disease familial amyloid polyneuropathy (FAP)
PAPER Penchala SC, Connelly S, Wang Y, Park MS, Zhao L, Baranczak A, Rappley I, Vogel H, Liedtke M, Witteles RM, Powers ET, Reixach N, Chan WK, Wilson IA, Kelly JW, Graef IA, Alhamadsheh MM
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9992-7. Epub 2013 May 28 PubMed: 23716704
PAPER Sekijima Y, Dendle MA, Kelly JW
Amyloid. 2006 Dec;13(4):236-49. PubMed: 17107884
PAPER Coelho T, Maia LF, Martins da Silva A, Waddington Cruz M, Planté-Bordeneuve V, Lozeron P, Suhr OB, Campistol JM, Conceição IM, Schmidt HH, Trigo P, Kelly JW, Labaudinière R, Chan J, Packman J, Wilson A, Grogan DR
Neurology. 2012 Aug 21;79(8):785-92. Epub 2012 Jul 25 PubMed: 22843282
PAPER Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, Schwartzkroin PA, Messing A, Tempel BL
Neuron. 1998 Apr;20(4):809-19. PubMed: 9581771
PAPER Brew HM, Gittelman JX, Silverstein RS, Hanks TD, Demas VP, Robinson LC, Robbins CA, McKee-Johnson J, Chiu SY, Messing A, Tempel BL
J Neurophysiol. 2007 Sep;98(3):1501-25. Epub 2007 Jul 18 PubMed: 17634333
PAPER Hornstrup LS, Frikke-Schmidt R, Nordestgaard BG, Tybjærg-Hansen A
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1441-7. Epub 2013 Apr 11 PubMed: 23580146
PAPER Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, Gorevic PD, Litchy WJ, Wiesman JF, Nordh E, Corato M, Lozza A, Cortese A, Robinson-Papp J, Colton T, Rybin DV, Bisbee AB, Ando Y, Ikeda S, Seldin DC, Merlini G, Skinner M, Kelly JW, Dyck PJ, Diflunisal Trial Consortium
JAMA. 2013 Dec 25;310(24):2658-67. PubMed: 24368466
PAPER Olofsson BO, Backman C, Karp K, Suhr OB
Transplantation. 2002 Mar 15;73(5):745-51. PubMed: 11907421
PAPER Liepnieks JJ, Zhang LQ, Benson MD
Neurology. 2010 Jul 27;75(4):324-7. PubMed: 20660862
ALZPEDIA CD33 is a transmembrane receptor of the innate immune system that is expressed on the surface of peripheral monocytes and microglial cells in the brain. CD33 was first implicated in Alzheimer’s disease genetics in 2008, and in 2011 reached genome-wide sig